| Zugriffe | |
|---|---|
| Omalizumab in chronic inducible urticaria: A real‐life study of efficacy, safety, predictors of treatment outcome and time to response | 220 |
| November 2024 | Dezember 2024 | Januar 2025 | Februar 2025 | März 2025 | April 2025 | Mai 2025 | |
|---|---|---|---|---|---|---|---|
| Omalizumab in chronic inducible urticaria: A real‐life study of efficacy, safety, predictors of treatment outcome and time to response | 4 | 9 | 4 | 7 | 5 | 13 | 0 |
| Zugriffe | |
|---|---|
| 2021_Yu_etal.pdf | 98 |
